polatuzumab vedotin
roche
['polar bear', 'dlbcl', 'lymsm', 'pola']
congress #eha2023 | presents initial safety data from ph iii polar bear trial. r-pola-mini-chp &amp; r-mini-chop had comparable safety profile &amp; were tolerable in elderly or frail pts with dlbcl. gi events were more common in pola group.
#lymhoma #lym #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm